Haswell: The Fourth-Generation Intel Core Processor von Hammarlund, Per, Martinez, Alberto J., Bajwa, Atiq A., Hill, David L., Hallnor, Erik, Jiang, Hong, Dixon, Martin, Derr, Michael, Hunsaker, Mikal, Kumar, Rajesh, Osborne, Randy B., Rajwar, Ravi, Singhal, Ronak, D'Sa, Reynold, Chappell, Robert, Kaushik, Shiv, Chennupaty, Srinivas, Jourdan, Stephan, Gunther, Steve, Piazza, Tom, Burton, Ted

Volltext

Optimized GNSS Cal/Val Site Selection for Expanding InSAR Viability in Areas With Low Phase Coherence: A Case Study for Southern Louisiana von Varugu, Bhuvan K., Jones, Cathleen E., Wang, Ke, Chen, Jingyi, Osborne, Randy L., Voyiadjis, George Z.

Volltext

First novel anti-tuberculosis drug in 40 years von Osborne, Randy

Volltext

Fresh from the biotech pipeline—2012 von Osborne, Randy

Volltext

First-in-class insomnia drug on the brink of approval nod von Osborne, Randy

Volltext

Synthetic peptide allergy vaccine shows efficacy von Osborne, Randy

Volltext

First-in-class insomnia drug on the brink of approval nod: Merck's dual orexin receptor antagonist suvorexant is approaching the regulatory finish line, 15 years after orexins were... von Osborne, Randy

Volltext

Fresh from the biotech pipeline--2012: FDA approvals hit a new high mark in 2012, with a December flurry of approvals. Orphan and fast-track drugs showed strong in the list Randy O... von Osborne, Randy

Volltext

Commercial interest waxes for IGF-1 blockers von Osborne, Randy

Volltext

Newsmaker: Constellation Pharmaceuticals von Osborne, Randy

Volltext

Constellation pharmaceuticals: replete with investor funds, the Cambridge, Massachusetts--based epigenetics firm is taking aim at methylases and demethylases linked to disease von Osborne, Randy

Volltext

Brand biologics grab 12 years' exclusivity, for now von Osborne, Randy

Volltext

The lengthening handshake: although mergers and acquisitions (MAs) failed to hit the heights some analysts had predicted in 2009, a new type of tiered transaction rose to prominenc... von Osborne, Randy

Volltext

The lengthening handshake: although mergers and acquisitions von Osborne, Randy

Volltext

The lengthening handshake von Osborne, Randy

Volltext

Ark floats gene therapy's boat, for now von Osborne, Randy

Volltext

US regulator wades into stem cell therapies for heart disease von Osborne, Randy

Volltext

Myriad stumbles, Wyeth closes on Alzheimer's von Osborne, Randy

Volltext

Buzz around Campath proof-of-concept trial in MS von Osborne, Randy

Volltext

FDA on warpath for Google links von Osborne, Randy

Volltext